Reetta Kälviäinen

25.9k total citations · 2 hit papers
179 papers, 7.2k citations indexed

About

Reetta Kälviäinen is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Reetta Kälviäinen has authored 179 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 123 papers in Psychiatry and Mental health, 92 papers in Pediatrics, Perinatology and Child Health and 54 papers in Cellular and Molecular Neuroscience. Recurrent topics in Reetta Kälviäinen's work include Epilepsy research and treatment (123 papers), Pharmacological Effects and Toxicity Studies (87 papers) and Neuroscience and Neuropharmacology Research (52 papers). Reetta Kälviäinen is often cited by papers focused on Epilepsy research and treatment (123 papers), Pharmacological Effects and Toxicity Studies (87 papers) and Neuroscience and Neuropharmacology Research (52 papers). Reetta Kälviäinen collaborates with scholars based in Finland, United States and United Kingdom. Reetta Kälviäinen's co-authors include Asla Pitkänen, Kaarina Partanen, Tuuli Salmenperä, Esa Mervaala, Torbjörn Tomson, Marja Äikiä, Eugen Trinka, Emilio Perucca, Elinor Ben‐Menachem and P. Riekkinen and has published in prestigious journals such as The Lancet, Nature Communications and PLoS ONE.

In The Last Decade

Reetta Kälviäinen

170 papers receiving 6.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ILAE Treatment Guidelines: Evidence‐based Analysis of Antiepileptic Drug Efficacy and Effectiveness as Initial Monotherapy for Epileptic Seizures and Syndromes

2006 523 citations Reetta Kälviäinen, Emilio Perucca et al. Epilepsia profile →
Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes

2013 502 citations Reetta Kälviäinen, Emilio Perucca et al. Epilepsia profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Reetta Kälviäinen Finland	46	5.0k	3.8k	2.5k	856	729	179	7.2k
Giuseppe Capovilla Italy	34	5.1k 1.0×	3.1k 0.8×	1.9k 0.7×	1.1k 1.3×	614 0.8×	107	6.8k
Mary Connolly Canada	34	4.6k 0.9×	2.8k 0.7×	1.6k 0.6×	1.2k 1.4×	806 1.1×	143	7.7k
John M. Pellock United States	49	7.9k 1.6×	6.5k 1.7×	2.9k 1.1×	804 0.9×	514 0.7×	174	10.2k
Cynthia L. Harden United States	46	4.2k 0.8×	2.9k 0.8×	1.5k 0.6×	984 1.1×	691 0.9×	161	6.3k
Elinor Ben‐Menachem Sweden	52	6.1k 1.2×	5.0k 1.3×	3.3k 1.3×	1.4k 1.6×	1.1k 1.5×	149	9.2k
Mohamad A. Mikati United States	45	3.4k 0.7×	2.6k 0.7×	1.7k 0.7×	658 0.8×	522 0.7×	264	6.7k
Douglas R. Nordli United States	30	6.9k 1.4×	4.2k 1.1×	2.6k 1.0×	1.5k 1.8×	624 0.9×	71	9.2k
Adam Strzelczyk Germany	44	4.2k 0.8×	3.2k 0.8×	1.7k 0.7×	531 0.6×	622 0.9×	296	5.7k
G. Avanzini Italy	49	4.0k 0.8×	2.3k 0.6×	3.8k 1.5×	2.1k 2.5×	967 1.3×	199	8.3k
Catherine Chiron France	56	6.0k 1.2×	4.4k 1.2×	2.4k 0.9×	1.6k 1.9×	756 1.0×	233	9.9k

Countries citing papers authored by Reetta Kälviäinen

Since Specialization

Citations

This map shows the geographic impact of Reetta Kälviäinen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reetta Kälviäinen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reetta Kälviäinen more than expected).

Fields of papers citing papers by Reetta Kälviäinen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reetta Kälviäinen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reetta Kälviäinen. The network helps show where Reetta Kälviäinen may publish in the future.

Co-authorship network of co-authors of Reetta Kälviäinen

This figure shows the co-authorship network connecting the top 25 collaborators of Reetta Kälviäinen. A scholar is included among the top collaborators of Reetta Kälviäinen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reetta Kälviäinen. Reetta Kälviäinen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Piña-Garza, J. Eric, Michael Chez, James C. Cloyd, et al.. (2024). Outpatient management of prolonged seizures and seizure clusters to prevent progression to a higher‐level emergency: Consensus recommendations of an expert working group. Epileptic Disorders. 26(4). 484–497. 10 indexed citations

Kälviäinen, Reetta, et al.. (2024). Access to justice in the light of everyday problems and prejudice: A pilot study on the experiences of people with epilepsy in Finland. Seizure. 120. 189–193. 1 indexed citations

Säïsänen, Laura, Jelena Hyppönen, Katri Silvennoinen, et al.. (2023). Detecting negative myoclonus during long-term home measurements using wearables. Clinical Neurophysiology. 156. 166–174.

Sipilä, Jussi & Reetta Kälviäinen. (2022). Comorbidities in patients with Unverricht–Lundborg disease ( EPM1 ). Acta Neurologica Scandinavica. 146(5). 690–693. 4 indexed citations

Silvennoinen, Katri, Laura Säïsänen, Jelena Hyppönen, et al.. (2022). Short‐ and long‐interval intracortical inhibition in EPM1 is related to genotype. Epilepsia. 64(1). 208–217. 8 indexed citations

Rissanen, Saara M., Jelena Hyppönen, Katri Silvennoinen, et al.. (2021). Wearable monitoring of positive and negative myoclonus in progressive myoclonic epilepsy type 1. Clinical Neurophysiology. 132(10). 2464–2472. 10 indexed citations

Kantanen, Anne-Mari, et al.. (2020). Outcome of status epilepticus and the predictive value of the EMSE and STESS scores: A prospective study. Seizure. 75. 115–120. 9 indexed citations

Väätäinen, Saku, et al.. (2017). Cost-Effectiveness of Brivaracetam As Adjunctive Therapy for Partial-Onset Epilepsy In The Finnish Setting. Value in Health. 20(9). A722–A722. 1 indexed citations

Kantanen, Anne-Mari, Matti Reinikainen, Ilkka Parviainen, & Reetta Kälviäinen. (2017). Long-term outcome of refractory status epilepticus in adults: A retrospective population-based study. Epilepsy Research. 133. 13–21. 53 indexed citations

10.

Halkoaho, Arja, et al.. (2015). Therapeutic misconception correlates with willingness to participate in clinical drug trials among patients with epilepsy; need for better counseling. Epilepsy & Behavior. 48. 29–34. 8 indexed citations

11.

Baulac, Michel, Hanneke de Boer, Christian E. Elger, et al.. (2015). Epilepsy priorities in Europe: A report of the ILAE‐IBE Epilepsy Advocacy Europe Task Force. Epilepsia. 56(11). 1687–1695. 71 indexed citations

12.

Julkunen, Petro, Laura Säïsänen, Mervi Könönen, et al.. (2013). TMS-EEG reveals impaired intracortical interactions and coherence in Unverricht-Lundborg type progressive myoclonus epilepsy (EPM1). Epilepsy Research. 106(1-2). 103–112. 31 indexed citations

13.

Trinka, Eugen, Wim Van Paesschen, Yngve Hallström, et al.. (2008). The komet study: an open-label, randomized, parallel-group trial comparing the efficacy and safety of levetiracetam with sodium valproate and carbamazepine as monotherapy in subjects with newly diagnosed epilepsy. Epilepsia. 49. 448–449. 5 indexed citations

14.

Parviainen, Ilkka, Reetta Kälviäinen, & Esko Ruokonen. (2007). Propofol and barbiturates for the anesthesia of refractory convulsive status epilepticus: pros and cons. Neurological Research. 29(7). 667–671. 40 indexed citations

15.

Heinonen, Seppo, et al.. (2006). Community‐based, Prospective, Controlled Study of Obstetric and Neonatal Outcome of 179 Pregnancies in Women with Epilepsy. Epilepsia. 47(1). 186–192. 133 indexed citations

16.

Lamusuo, Salla, Leena Jutila, Aarne Ylinen, et al.. (2001). [18F]FDG-PET Reveals Temporal Hypometabolism in Patients With Temporal Lobe Epilepsy Even When Quantitative MRI and Histopathological Analysis Show Only Mild Hippocampal Damage. Archives of Neurology. 58(6). 933–933. 64 indexed citations

17.

Äikiä, Marja, Tuuli Salmenperä, Kaarina Partanen, & Reetta Kälviäinen. (2001). Verbal Memory in Newly Diagnosed Patients and Patients with Chronic Left Temporal Lobe Epilepsy. Epilepsy & Behavior. 2(1). 20–27. 68 indexed citations

18.

Pitkänen, A., Mikko P. Laakso, Reetta Kälviäinen, et al.. (1996). Severity of hippocampal atrophy correlates with the prolongation of MRI T sub 2 relaxation time in temporal lobe epilepsy but not in Alzheimer's disease. Neurology. 46(6). 1724–1730. 62 indexed citations

19.

Sivenius, Juhani, Aarne Ylinen, Reetta Kälviäinen, & P. Riekkinen. (1994). Long-term Study With Gabapentin in Patients With Drug-Resistant Epileptic Seizures. Archives of Neurology. 51(10). 1047–1050. 18 indexed citations

20.

Sivenius, Juhani, Reetta Kälviäinen, Aarne Ylinen, & P. Riekkinen. (1991). Double‐Blind Study of Gabapentin in the Treatment of Partial Seizures. Epilepsia. 32(4). 539–542. 143 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact